AI
| Followers | 842 |
| Posts | 122790 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Friday, February 25, 2011 4:19:15 PM
FoB Cheat Sheet
This chart shows why the hullabaloo over the 12-year exclusivity
period for US biologics is much ado about nothing (#msg-59912094).
For every big-selling biologic, US patent protection continues longer
than the statutory exclusivity period.
(The 12-year exclusivity could become consequential if the
US patents on these drugs were found to be unenforceable,
but there’s no indication that such an outcome is likely.)
Source: http://www.pharma-mag.com/Portals/0/Whitepapers/newport-biologics.pdf
This chart shows why the hullabaloo over the 12-year exclusivity
period for US biologics is much ado about nothing (#msg-59912094).
For every big-selling biologic, US patent protection continues longer
than the statutory exclusivity period.
(The 12-year exclusivity could become consequential if the
US patents on these drugs were found to be unenforceable,
but there’s no indication that such an outcome is likely.)
Source: http://www.pharma-mag.com/Portals/0/Whitepapers/newport-biologics.pdf
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
